Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma

William J. Schirmer, W. Scott Melvin, Robert M. Rush, Thomas M. O'Dorisio, Rodney V. Pozderac, John O. Olsen, E. Christopher Ellison

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background. The present study evaluates 111In-pentetreotide scanning as a method for detection of gastrinomas. Operative findings serve as the benchmark for comparison of the efficacy of 111In-pentetreotide versus conventional imaging studies. Methods. Twelve patients (seven female and five male; age, 37 to 80 years) with histologic confirmation of gastrinoma underwent thin section dynamic computed tomography (CT) scanning and 111In-pentetreotide scanning. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 111In-pentetreotide and CT scanning are compared on the basis of tumor size and location. Results. Thirty discrete foci of intrahepatic and extrahepatic tumors were detected at operation. CT scanning detected three of nine pancreaticoduodenal lesions, whereas eight of these nine extrahepatic primary tumors were imaged by 111In-pentetreotide scanning. No false-positive 111In-pentetreotide scans were noted. The sensitivity of CT scanning for detection of metastatic disease was 56% versus 94% for the 111In-pentetreotide scan. Successful CT imaging was highly dependent on tumor size. No tumor smaller than 1 cm was imaged by CT, whereas four of seven lesions greater than 1 cm were imaged by 111In-pentetreotide scintigraphy. The smallest gastrinoma imaged by 111In-pentetreotide scanning was a 4 mm duodenal tumor. Conclusions. 111In-pentetreotide scanning, was superior to CT scanning for localizing gastrinomas. Further studies are required to determine whether 111In-pentetreotide scans will complement or replace traditional imaging methods.

Original languageEnglish (US)
Pages (from-to)1105-1114
Number of pages10
JournalSurgery
Volume118
Issue number6
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Gastrinoma
Tomography
Neoplasms
pentetreotide
Benchmarking
Radionuclide Imaging

ASJC Scopus subject areas

  • Surgery

Cite this

Schirmer, W. J., Melvin, W. S., Rush, R. M., O'Dorisio, T. M., Pozderac, R. V., Olsen, J. O., & Ellison, E. C. (1995). Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma. Surgery, 118(6), 1105-1114. https://doi.org/10.1016/S0039-6060(05)80121-7

Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma. / Schirmer, William J.; Melvin, W. Scott; Rush, Robert M.; O'Dorisio, Thomas M.; Pozderac, Rodney V.; Olsen, John O.; Ellison, E. Christopher.

In: Surgery, Vol. 118, No. 6, 1995, p. 1105-1114.

Research output: Contribution to journalArticle

Schirmer, WJ, Melvin, WS, Rush, RM, O'Dorisio, TM, Pozderac, RV, Olsen, JO & Ellison, EC 1995, 'Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma', Surgery, vol. 118, no. 6, pp. 1105-1114. https://doi.org/10.1016/S0039-6060(05)80121-7
Schirmer, William J. ; Melvin, W. Scott ; Rush, Robert M. ; O'Dorisio, Thomas M. ; Pozderac, Rodney V. ; Olsen, John O. ; Ellison, E. Christopher. / Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma. In: Surgery. 1995 ; Vol. 118, No. 6. pp. 1105-1114.
@article{5213f070e9244e5f8f48ae3420af6584,
title = "Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma",
abstract = "Background. The present study evaluates 111In-pentetreotide scanning as a method for detection of gastrinomas. Operative findings serve as the benchmark for comparison of the efficacy of 111In-pentetreotide versus conventional imaging studies. Methods. Twelve patients (seven female and five male; age, 37 to 80 years) with histologic confirmation of gastrinoma underwent thin section dynamic computed tomography (CT) scanning and 111In-pentetreotide scanning. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 111In-pentetreotide and CT scanning are compared on the basis of tumor size and location. Results. Thirty discrete foci of intrahepatic and extrahepatic tumors were detected at operation. CT scanning detected three of nine pancreaticoduodenal lesions, whereas eight of these nine extrahepatic primary tumors were imaged by 111In-pentetreotide scanning. No false-positive 111In-pentetreotide scans were noted. The sensitivity of CT scanning for detection of metastatic disease was 56{\%} versus 94{\%} for the 111In-pentetreotide scan. Successful CT imaging was highly dependent on tumor size. No tumor smaller than 1 cm was imaged by CT, whereas four of seven lesions greater than 1 cm were imaged by 111In-pentetreotide scintigraphy. The smallest gastrinoma imaged by 111In-pentetreotide scanning was a 4 mm duodenal tumor. Conclusions. 111In-pentetreotide scanning, was superior to CT scanning for localizing gastrinomas. Further studies are required to determine whether 111In-pentetreotide scans will complement or replace traditional imaging methods.",
author = "Schirmer, {William J.} and Melvin, {W. Scott} and Rush, {Robert M.} and O'Dorisio, {Thomas M.} and Pozderac, {Rodney V.} and Olsen, {John O.} and Ellison, {E. Christopher}",
year = "1995",
doi = "10.1016/S0039-6060(05)80121-7",
language = "English (US)",
volume = "118",
pages = "1105--1114",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma

AU - Schirmer, William J.

AU - Melvin, W. Scott

AU - Rush, Robert M.

AU - O'Dorisio, Thomas M.

AU - Pozderac, Rodney V.

AU - Olsen, John O.

AU - Ellison, E. Christopher

PY - 1995

Y1 - 1995

N2 - Background. The present study evaluates 111In-pentetreotide scanning as a method for detection of gastrinomas. Operative findings serve as the benchmark for comparison of the efficacy of 111In-pentetreotide versus conventional imaging studies. Methods. Twelve patients (seven female and five male; age, 37 to 80 years) with histologic confirmation of gastrinoma underwent thin section dynamic computed tomography (CT) scanning and 111In-pentetreotide scanning. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 111In-pentetreotide and CT scanning are compared on the basis of tumor size and location. Results. Thirty discrete foci of intrahepatic and extrahepatic tumors were detected at operation. CT scanning detected three of nine pancreaticoduodenal lesions, whereas eight of these nine extrahepatic primary tumors were imaged by 111In-pentetreotide scanning. No false-positive 111In-pentetreotide scans were noted. The sensitivity of CT scanning for detection of metastatic disease was 56% versus 94% for the 111In-pentetreotide scan. Successful CT imaging was highly dependent on tumor size. No tumor smaller than 1 cm was imaged by CT, whereas four of seven lesions greater than 1 cm were imaged by 111In-pentetreotide scintigraphy. The smallest gastrinoma imaged by 111In-pentetreotide scanning was a 4 mm duodenal tumor. Conclusions. 111In-pentetreotide scanning, was superior to CT scanning for localizing gastrinomas. Further studies are required to determine whether 111In-pentetreotide scans will complement or replace traditional imaging methods.

AB - Background. The present study evaluates 111In-pentetreotide scanning as a method for detection of gastrinomas. Operative findings serve as the benchmark for comparison of the efficacy of 111In-pentetreotide versus conventional imaging studies. Methods. Twelve patients (seven female and five male; age, 37 to 80 years) with histologic confirmation of gastrinoma underwent thin section dynamic computed tomography (CT) scanning and 111In-pentetreotide scanning. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 111In-pentetreotide and CT scanning are compared on the basis of tumor size and location. Results. Thirty discrete foci of intrahepatic and extrahepatic tumors were detected at operation. CT scanning detected three of nine pancreaticoduodenal lesions, whereas eight of these nine extrahepatic primary tumors were imaged by 111In-pentetreotide scanning. No false-positive 111In-pentetreotide scans were noted. The sensitivity of CT scanning for detection of metastatic disease was 56% versus 94% for the 111In-pentetreotide scan. Successful CT imaging was highly dependent on tumor size. No tumor smaller than 1 cm was imaged by CT, whereas four of seven lesions greater than 1 cm were imaged by 111In-pentetreotide scintigraphy. The smallest gastrinoma imaged by 111In-pentetreotide scanning was a 4 mm duodenal tumor. Conclusions. 111In-pentetreotide scanning, was superior to CT scanning for localizing gastrinomas. Further studies are required to determine whether 111In-pentetreotide scans will complement or replace traditional imaging methods.

UR - http://www.scopus.com/inward/record.url?scp=0028841608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028841608&partnerID=8YFLogxK

U2 - 10.1016/S0039-6060(05)80121-7

DO - 10.1016/S0039-6060(05)80121-7

M3 - Article

C2 - 7491530

AN - SCOPUS:0028841608

VL - 118

SP - 1105

EP - 1114

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 6

ER -